Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy.

Yen HH, Yang CW, Su WW, Soon MS, Wu SS, Lin HJ.

BMC Gastroenterol. 2012 Jun 8;12:66. doi: 10.1186/1471-230X-12-66.

2.

Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy.

Sung JJ, Suen BY, Wu JC, Lau JY, Ching JY, Lee VW, Chiu PW, Tsoi KK, Chan FK.

Am J Gastroenterol. 2014 Jul;109(7):1005-10. doi: 10.1038/ajg.2014.105. Epub 2014 Apr 29.

PMID:
24777150
3.

Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.

Sung JJ, Barkun A, Kuipers EJ, Mössner J, Jensen DM, Stuart R, Lau JY, Ahlbom H, Kilhamn J, Lind T; Peptic Ulcer Bleed Study Group.

Ann Intern Med. 2009 Apr 7;150(7):455-64. Epub 2009 Feb 16.

PMID:
19221370
4.

Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.

Tseng GY, Fang CT, Lin HJ, Yang HB, Tseng GC, Wang PC, Liao PC, Cheng YT, Huang CH.

Aliment Pharmacol Ther. 2009 Aug 15;30(4):406-13. doi: 10.1111/j.1365-2036.2009.04049.x. Epub 2009 May 26.

5.

Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata.

Lanas A, Carrera-Lasfuentes P, García-Rodríguez LA, García S, Arroyo-Villarino MT, Ponce J, Bujanda L, Calleja JL, Polo-Tomas M, Calvet X, Feu F, Perez-Aisa A.

Scand J Gastroenterol. 2014 Oct;49(10):1181-90. doi: 10.3109/00365521.2014.950694. Epub 2014 Aug 21.

PMID:
25144754
6.

Effect of intravenous proton pump inhibitor regimens and timing of endoscopy on clinical outcomes of peptic ulcer bleeding.

Liu N, Liu L, Zhang H, Gyawali PC, Zhang D, Yao L, Yang Y, Wu K, Ding J, Fan D.

J Gastroenterol Hepatol. 2012 Sep;27(9):1473-9. doi: 10.1111/j.1440-1746.2012.07191.x.

PMID:
22646140
8.

Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.

Tsai JJ, Hsu YC, Perng CL, Lin HJ.

Br J Clin Pharmacol. 2009 Mar;67(3):326-32. doi: 10.1111/j.1365-2125.2008.03359.x. Epub 2008 Dec 10.

9.

Intravenous pantoprazole as an adjuvant therapy following successful endoscopic treatment for peptic ulcer bleeding.

Wang J, Yang K, Ma B, Tian J, Liu Y, Bai Z, Jiang L, Sun S, Li J, Liu R, Hao X, He X.

Can J Gastroenterol. 2009 Apr;23(4):287-99. Review.

10.

Meta-analysis: comparison of oral vs. intravenous proton pump inhibitors in patients with peptic ulcer bleeding.

Tsoi KK, Hirai HW, Sung JJ.

Aliment Pharmacol Ther. 2013 Oct;38(7):721-8. doi: 10.1111/apt.12441. Epub 2013 Aug 5.

11.

Intravenous esomeprazole for prevention of peptic ulcer re-bleeding: rationale/design of Peptic Ulcer Bleed study.

Sung JJ, Mössner J, Barkun A, Kuipers EJ, Lau J, Jensen D, Stuart R, Junghard O, Olsson G; Pub Study Group.

Aliment Pharmacol Ther. 2008 Apr;27(8):666-77. doi: 10.1111/j.1365-2036.2008.03631.x. Epub 2008 Jan 28.

12.

Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

Wei KL, Tung SY, Sheen CH, Chang TS, Lee IL, Wu CS.

J Gastroenterol Hepatol. 2007 Jan;22(1):43-6.

PMID:
17201879
13.

Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis.

Tringali A, Manta R, Sica M, Bassotti G, Marmo R, Mutignani M.

Br J Clin Pharmacol. 2017 Aug;83(8):1619-1635. doi: 10.1111/bcp.13258. Epub 2017 Mar 21. Review.

PMID:
28181291
14.

Proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding.

Mesihovic R, Vanis N, Mehmedovic A, Gornjakovic S, Gribajcevic M.

Med Arh. 2009;63(6):323-7.

PMID:
20380111
15.

Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.

Javid G, Zargar SA, U-Saif R, Khan BA, Yatoo GN, Shah AH, Gulzar GM, Sodhi JS, Khan MA.

J Gastroenterol Hepatol. 2009 Jul;24(7):1236-43. doi: 10.1111/j.1440-1746.2009.05900.x.

PMID:
19682194
16.
17.

Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors.

Mehmedović-Redzepović A, Mesihović R, Prnjavorac B, Kulo A, Merlina K.

Med Glas (Zenica). 2011 Feb;8(1):151-7.

PMID:
21263414
18.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

19.

Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea.

Choi KD, Kim N, Jang IJ, Park YS, Cho JY, Kim JR, Shin JM, Jung HC, Song IS.

J Gastroenterol Hepatol. 2009 Oct;24(10):1617-24. doi: 10.1111/j.1440-1746.2009.05939.x. Epub 2009 Aug 3.

PMID:
19686407
20.

Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding.

Neumann I, Letelier LM, Rada G, Claro JC, Martin J, Howden CW, Yuan Y, Leontiadis GI.

Cochrane Database Syst Rev. 2013 Jun 12;(6):CD007999. doi: 10.1002/14651858.CD007999.pub2. Review.

PMID:
23760821

Supplemental Content

Support Center